Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

Preventable hospital admissions related to medication (HARM): cost analysis of the HARM study.

Leenderste AJ,  Van Den Bemt PM, Poolman JB, et al. Preventable hospital admissions related to medication (HARM): cost analysis of the HARM study. Value Health. 2011;14(1):34-40. 10.1016/j.jval.2010.10.024

Save
Print
March 1, 2011
Leendertse AJ, van den Bemt PMLA, Poolman JB, et al. Value Health. 2011;14(1):34-40.
View more articles from the same authors.

Adverse drug events (ADE) in the outpatient setting can result in hospital admission and are largely preventable. This study used data from the earlier Hospital Admissions Related to Medication (HARM) study to estimate the cost (medical cost to the health system and loss of patient productivity) of each ADE-related hospital admission. The expense of each ADE can be significant, suggesting programs to reduce ADE may be cost-neutral or cost-saving.

Save
Print
Cite
Citation

Leenderste AJ,  Van Den Bemt PM, Poolman JB, et al. Preventable hospital admissions related to medication (HARM): cost analysis of the HARM study. Value Health. 2011;14(1):34-40. 10.1016/j.jval.2010.10.024

Related Resources From the Same Author(s)
Related Resources